ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,537Medicare Part D Prescriptions Filled, Including Refills

Rank: 609 out of 3734

$641K Total Retail Price of All Prescriptions

Rank: 408 out of 3734

305 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
37% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 305 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

15% of this provider’s 305 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 7,404 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$67 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
AMLODIPINE BESYLATE 266 248 1 5
LEVOTHYROXINE SODIUM 252 218 2 2
HYDROCODONE-ACETAMINOPHEN 210 145 S3 3 12
ATENOLOL 193 153 4 13
GABAPENTIN 183 119 5 17
FUROSEMIDE 179 156 6 7
LISINOPRIL 159 115 7 3
OMEPRAZOLE 152 124 8 4
SIMVASTATIN 146 117 9 1
METOPROLOL TARTRATE 143 130 10 6
BYSTOLIC 134 130 11 148
LOSARTAN POTASSIUM 130 104 12 21
ATORVASTATIN CALCIUM 118 82 13 11
POLYETHYLENE GLYCOL 3350 117 88 14 53
POTASSIUM CHLORIDE 113 90 15 19
WARFARIN SODIUM 110 79 16 10
NEXIUM 108 81 17 36
METFORMIN HCL 106 74 18 8
CARVEDILOL 106 105 18 30
PRAVASTATIN SODIUM 99 77 20 15
FAMOTIDINE 99 85 20 60
PREDNISONE 96 87 22 42
TRAMADOL HCL 91 49 23 20
ALLOPURINOL 90 46 24 33
TAMSULOSIN HCL 84 56 25 29
SYNTHROID 84 84 25 47
KLOR-CON 10 82 72 27 140
CHLORTHALIDONE 80 64 28 179
METOPROLOL SUCCINATE 80 80 28 14
CLONIDINE HCL 78 76 30 79
PANTOPRAZOLE SODIUM 78 63 30 22
PRADAXA 75 70 32 205
GLYBURIDE 74 46 R 33 64
SERTRALINE HCL 73 63 34 18
LANTUS 69 58 35 54
CELEBREX 68 46 36 69
ADVAIR DISKUS 67 45 37 35
MICARDIS 66 66 38 349
FELODIPINE ER 65 59 39 132
AMLODIPINE BESYLATE-BENAZEPRIL 63 58 40 56
DOXAZOSIN MESYLATE 62 59 41 100
HYDROCHLOROTHIAZIDE 61 31 42 9
CARBIDOPA-LEVODOPA 60 48 43 92
DIGOXIN 59 56 44 43
DILTIAZEM 24HR CD 57 44 45 97
BACLOFEN 56 0 46 142
CLOPIDOGREL 54 52 47 23
VESICARE 52 28 48 157
ISOSORBIDE MONONITRATE ER 50 50 49 34
SINGULAIR 50 44 49 95
CYMBALTA 50 32 49 67
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.